Biphasic effect of norepinephrine in the regulation of hepatic tyrosine transaminase activity.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D002940:Circadian Rhythm; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D007016:Hypophysectomy; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008660:Metabolism / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology*; D010902:Pituitary Gland / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D014176:Protein Biosynthesis; D011732:Pyridoxal Phosphate; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D013644:Tartrates; D013997:Time Factors; D014444:Tyrosine Transaminase / Q000378:metabolism*
D013644:Tartrates; D003609:Dactinomycin; D011732:Pyridoxal Phosphate; D012313:RNA; D003513:Cycloheximide; D011433:Propranolol; D014444:Tyrosine Transaminase; D004878:Ergotamine; D009638:Norepinephrine